Clinical trials
Phase 3 Ovarian Neoplasms trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Terminated | 6 |
| Completed | 5 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 4 |
| Pfizer | 4 |
| AstraZeneca | 2 |
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| CanariaBio Inc. | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 21 |
| Fallopian Tube Neoplasms | 10 |
| Carcinoma, Ovarian Epithelial | 4 |
| Peritoneal Neoplasms | 3 |
| Breast Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.